Disclosures: Liang Wen: Nothing to Disclose, Yixiao Yang: Nothing to Disclose, Tingbo Liang: Nothing to Disclose 2639 PREDICTING SURVIVAL AMONG PATIENTS WITH EARLY- TO INTERMEDIATE-STAGE HCC: MIAMI LIVER CANCER ESTIMATOR OF SURVIVAL (MILES) SCORE David Goldberg 1 David Kaplan 2 Binu John 1 Neelima Gaddipati 1 Sirisha Gaddipati 1 Yalda Zarnegarnia 1 Peter Reese 2 Catherine Blandon 1 , 1 University of Miami, 2 University of Pennsylvania Background: Staging and prognostication of hepatocellular carcinoma (HCC) differs from other cancers because it must account for tumor burden as well as function of the diseased organ (i.e., liver)
When you drop a significant amount of body fat, the connective tissue and water that surrounded and supported that fat disappears with it
Two distinct medication classes have emerged as evidence-backed options for weight management: bupropion, an antidepressant that increases norepinephrine and dopamine, and GLP-1 receptor agonists, which regulate appetite hormones
Practice preventative health measures like frequent hand-washing (for at least 20 seconds) and covering coughs and sneezes
Health and Wellness: Oral and Injectable Medications for Type 2 Diabetes
GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomized controlled trials
